Cite
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
MLA
Granger, Christopher B., et al. “Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-Ventricular Systolic Function Intolerant to Angiotensin-Converting-Enzyme Inhibitors: The CHARM-Alternative Trial.” Lancet, vol. 362, no. 9386, Sept. 2003, pp. 772–76. EBSCOhost, https://doi.org/10.1016/S0140-6736(03)14284-5.
APA
Granger, C. B., McMurray, J. J. V., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., ostergren, J., Pfeffer, M. A., & Swedberg, K. (2003). Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet, 362(9386), 772–776. https://doi.org/10.1016/S0140-6736(03)14284-5
Chicago
Granger, Christopher B., John J. V. McMurray, Salim Yusuf, Peter Held, Eric L. Michelson, Bertil Olofsson, Jan ostergren, Marc A. Pfeffer, and Karl Swedberg. 2003. “Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-Ventricular Systolic Function Intolerant to Angiotensin-Converting-Enzyme Inhibitors: The CHARM-Alternative Trial.” Lancet 362 (9386): 772–76. doi:10.1016/S0140-6736(03)14284-5.